CYP1A2 Gene Polymorphism and Theophylline Level in Asthma

Amelia Lorensia, Zullies Ikawati, Tri Murti Andayani, Daniel Maranatha, Mariana Wahyudi


BACKGROUND: Aminophylline (theophylline) is one of the most frequent asthma therapies in Indonesia, although it remains as a narrow therapy. The effects of drugs are individualized and strongly influenced by genetic, one of which is CYP1A2 gene polymorphisms. This study aimed to determine the profile of CYP1A2 polymorphism and theophylline level in asthma exacerbation patients receiving intravenous aminophylline therapy.

METHODS: This cross sectional study was conducted in the emergency room (ER), to adults asthma exacerbation patients without complication (n=27), visiting the ER. The gene polymorphism data were compared with theophylline levels in the blood using chi-square test.

RESULTS: In the CYP1A2 gene polymorphism profile, the most common heterozygous alleles are T/G genotype of CYP1A2*1E and C/A genotype of CYP1A2*1F. Most homozygote alleles exist in CYP1A2*1D and CYP1A2*1F. There was significant difference between CYP1A2*1D (p<0.005), CYP1A2*1E (p<0.023) and CYP1A2*1F (p<0.000) polymorphisms and theophylline level.

CONCLUSION: CYP1A2*1D, CYP1A2*1E and CYP1A2*1F gene polymorphisms had an effect on theophylline levels. However, no one experienced an overdose theophylline, and no correlation between theophylline levels with CYP1A2 gene polymorphism.

KEYWORDS: exacerbation asthma, intravenous aminophylline, CYP1A2 polymorphism gene, theophylline

Full Text:



Global Initiative for Asthma (GINA). Global Strategy for Asthma Management and Prevention (Update). [No Location]: GINA; 2018, article.

National Asthma Education and Prevention Program. Guidelines for the diagnosis and management of asthma. Expert Panel Report 3. Maryland: National Institutes of Health and National Heart Lung and Blood Institute; 2007, article.

She J, Johnston M, Hays RD. Asthma outcome measures: asthma exacerbation. Expert Rev Pharmacoeconomics Outcomes Res. 2011; 11: 447-53, CrossRef.

Kementrian Kesehatan Republik Indonesia. Keputusan Menteri Kesehatan Republik Indonesia Nomor 312/MENKES/SK/IX/2015 tentang Daftar Obat Essensial 2015. Jakarta: Kementerian Kesehatan Republik Indonesia; 2015.

Kementrian Kesehatan Republik Indonesia. Keputusan Menteri Kesehatan Republik Indonesia Nomor HK.02.02/MENKES/523/2015 tentang Formularium Nasional. Jakarta: Kementerian Kesehatan Republik Indonesia; 2015.

Travers AH, Jones AP, Camargo CA, Milan SJ, Rowe BH. Intravenous beta(2)-agonists versus intravenous aminophylline for acute asthma. Cochrane Database Syst Rev. 2012; 12: CD010256, CrossRef.

Roberts G, Newsom D, Gomez K, Raffles A, Saglani S, Begent J. Intravenous salbutamol bolus compared with an aminophylline infusion in children with severe asthma: a randomised controlled trial. Thorax. 2003; 58: 306-10, CrossRef.

Xu YJ. Development of theophylline in treatment of asthma and chronic obstructive pulmonary disease. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2004; 26: 319-22, PMID.

Lorensia A, Wahjuningsih E, Canggih B, Lisiska N. Pharmacist’s strategies in treating asthma bronchiale outpatient. J Trop Pharm Chem. 2011; 1: 177-91, CrossRef.

Lorensia A, Wahjuningsih E, Supriadi. Keamanan penggunaan aminophylline pada asma di rumah sakit delta surya sidoarjo. Indones J Clin Pharm. 2012; 1: 154-61, article.

Lorensia A, Canggih B, Wijaya RI. Analisa adverse drug reactions pada pasien asma di suatu rumah sakit Surabaya. Jurnal Farmasi Indonesia. 2013; 6: 142-50, article.

Lorensia A, Amalia RA. Studi farmakovigilans pengobatan asma pada pasien rawat inap di suatu rumah sakit di bojonegoro. Jurnal Ilmiah Manuntung. 2015; 1: 8-18, article.

Lorensia A, Ikawati Z, Andayani TM, Maranatha D, Wahjudi M. Comparison of electrolyte disturbance of using intravenous aminophylline versus nebulization salbutamol for exacerbation asthma in Surabaya Indonesia. Int J Pharm Clin Res. 2016; 8: 221-8, article.

Rugelj N, Trobec KC, Pišlar M, Brguljan PM, Košnik M, Mrhar A. Evaluation of theophylline therapeutic drug monitoring service. Zdrav Vestn. 2015; 84: 191-202, CrossRef.

Hart SP. Should aminophylline be abandoned in the the treatment of acute asthma in adults? Q J Med. 2000; 93: 761-5, CrossRef.

Parameswaran K, Belda J, Rowe BH. Addition of intravenous aminophylline to beta2-agonists in adults with acute asthma. Cochrane Database Syst Rev. 2000; 4: CD002742, CrossRef.

Fotinos C, Dodson S. Is there a role for theophylline in treating patients with asthma? Family Practice Inquiries Network. 2002; 51: [np].

Makino S, Adachi M, Ohta K, Kihara N, Nakajima S, Nishima S, et al. A prospective survey on safety of sustained-release theophylline in treatment of asthma and COPD. Allergol Int. 2006; 55: 395-402, CrossRef.

Tyagi N, Gulati K, Vijayan VK, Ray A. A study to monitor adverse drug reactions in patients of chronic obstructive pulmonary disease: focus on theophylline. Indian J Chest Dis Allied Sci. 2008; 50: 199-202, article.

Tse SM, Tantisira K, Weiss ST. The pharmacogenetics and pharmacogenomics of asthma therapy. Pharmacogenomics J. 2011; 11: 383-92, CrossRef.

Fenech AG, Grech G. Pharmacogenetics: where do we stand? J Malta Coll Pharm Pract. 2011; 11: 25-33, article.

Baba K, Yamaguchi E. Issues associated with stepwise management of bronchial asthma. Allergol Int. 2005; 54: 203-8, CrossRef.

Uslu A, Ogus C, Ozdemir T, Bilgen T, Tosun O, Keser I. The effect of CYP1A2 gene polymorphisms on Theophylline metabolism and chronic obstructive pulmonary disease in Turkish patients. Biochem Mol Biol Rep. 2010; 43: 530-4, CrossRef.

Obase Y, Shimoda T, Kawano T, Saeki S, Tomari SY, Mitsuta-Izaki K, et al. Polymorphisms in the CYP1A2 gene and theophylline metabolism in patients with asthma. Clin Pharmacol Ther. 2003; 73: 468-74, CrossRef.

Yasuda SU, Zhang L, Huang SM. The role of ethnicity in variability in response to drugs: focus on clinical pharmacology studies. Clin Pharmacol Ther. 2008; 84: 417-23, CrossRef.

Belle DJ, Singh H. Genetic factors in drug metabolism. Am Fam Physician. 2008; 77: 1553-60, PMID.

Johnson JA. Ethnic differences in cardiovascular drug response: potential contribution of pharmacogenetics. Circulation. 2009; 118: 1383-93, CrossRef.

Yue QY, Svensson JO, Alm C, Sjoqvist F, Sawe J. Interindividual and interethnic differences in the demethylation and glucuronidation of codeine. Br J Clin Pharmacol. 1989; 28: 629-37, CrossRef.

Zhou HH, Sheller JR, Wood M, Wood AJ. Caucasians are more sensitive than Chinese to the cardiovascular and respiratory effects of morhipne but less to the gastrointestinal side effects. Clin Res. 1990; 38: 968A.

Queljoe DD, Wahjudi M, Erdiansyah M, Suryadinata RV, Lorensia A. Studi pendahuluan polimorfisme genetik gen cyp1a2*1f pada pasien asma dan non-asma di Indonesia. Indones J Clin Pharm. 2014; 4: 8-16, article.

SNPedia [Internet]. rs762551 [cited 2016 Aug 2]. Available from:

National Asthma Council Australia. Asthma Management Handbook. Melbourne: National Asthma Council Australia; 2006.

Fong N. Aminophylline/Theophylline: Loading and maintenance dose. Norwich: NHS Trust - East Lancashire Hospitals; 2011.

Scottish Intercollegiate Guidelines Network. British Guideline on the Management of Asthma. Edinburgh: British Thoracic Society; 2011, article.

Singh AS, Masuku MB. Sampling techniques & determination of sample size in applied statistics research: an overview. Int J Economics Commerce Manag. 2014; 2: 1-22, article.

Lorensia A, Ikawati Z, Andayani TM, Suryadinata RV, Hartoro KAA, Firanita LD. Efektifitas dan risiko toksisitas aminofilin intravena pada pengobatan awal serangan asma efektifitas dan risiko toksisitas aminofilin intravena pada pengobatan awal serangan asma. Indones J Clin Pharm. 2018; 7: 78-88, article.

Chida M, Yokoi T, Fukui T, Kinoshita M, Yokota J, Kamataki T. Detection of three genetic polymorphisms in the 5′-flanking region and intron I of human CYP1A2 in the Japanese population. Jpn J Cancer Res. 1999; 90: 899-902, CrossRef.


Copyright (c) 2019 The Prodia Education and Research Institute

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.


Indexed by:






The Prodia Education and Research Institute